INTRODUCTION
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a frequent and heterogeneous X-chromosomelinked enzyme abnormality. As G6PD plays a key role in maintaining erythrocytes, G6PD deficiency possibly results in acute hemolysis after exposure to various oxidative stresses, including infections, medications, and fava beans (favism). A striking correlation is observed between the prevalence of G6PD deficiency and historical malaria endemicity, particularly in tropical and sub-tropical areas (W. H.O. Working Group, 1989) . Therefore, it is important to detect and inform G6PD-deficient individuals in and from areas in which malaria is endemic before exposing such individuals to oxidative stress in order to avoid acute hemolytic attack, especially hemolytic attack caused by primaquine.
For field screening of G6PD deficiency, the test used should be simple to perform and affordable. It is also advantageous if the test reagents can be stored and the reaction can be carried out at around room temperature, particularly in areas with an insufficient supply of electricity.
Several tests, including the G6PD spot test (Fairbanks and Beutler, 1962) , fluorescent spot test (Beutler, 1966) , and blue formazan spot test (Fujii et al ., 1984) have been developed for field screening of G6PD deficiency; however most of them are complicated or expensive. One of the tests, the blue formazan spot test (BFST) (Fujii et al ., 1984; Pujades et al ., 1999) , has been used for field studies because of its comparatively simple procedure and sufficiently (Tantular et al . 1999 ) in the Taninthayi Division in Myanmar and on Bum Island in Indonesia, 1998. Prior to the study, the outline and procedures of this research were discussed within the committees of the national and local governments in Indonesia and Myanmar. The participants were orally informed of and gave consent to the examination twice before screening and blood drawing. We did not obtain written informed consent from each participant because of the opinion of local co-organizers about the participants' literacy and differences of local culture. The field samples were used to assess the sensitivity and specificity of SSS using BFST as the standard. We also compared the analysis as the standard. With the DEAE-Sephadex A-50TM system, nearly 20% of G6PD-deficient samples were judged as normal. The red-colored hemoglobin in the reaction mixture together with the translucent DEAE-Sephadex A-50TM particles may cause misdiagnosis. The proportion of the samples with normal activity that were diagnosed as 'normal' was 98% with DEAESephacelTM and 100% with DEAE-Sephadex A-50TM.
The sensitivity and specificity in field tests are shown in Table 2 . We used BFST as the standard because a previous study using the samples of genetically diagnosed G6PD-deficient patients showed that BFST had 100% sensitivity in hemizygotes and 75% in heterozygotes and 100% specificity (Pujades et al ., 1999) . The sensitivity was significantly higher in males than in females when we use DEAE-Sephacel as anion-exchanger (P=0.04). Neither the sensitivity nor specificity differed significantly between DEAE-SephadexTM and DEAE-SephacelTM.
Comparison of field testing with laboratory assessment revealed that the sensitivity of field testing was lower than that of laboratory assessment. The P-value was 0.03 using DEAE-Sephadex A-50 and less than 0.001 using DEAESephacel. We found no difference in specificity. In field assessment, the sensitivity was significantly higher among males when we used DEAE-Sephacel (p=0.04). The actual value of the sensitivity was also high among males tested with DEAE-Sephacel, although there was no significant difference (p=0.12). We suppose the discrepancy between laboratory and field assessments may be due to 3 reasons. One is the difference of genetic status between males and females. Because G6PD deficiency is an X-chromosomelinked abnormality, the enzyme activity is particularly vari- The crude G6PD level of blood may also be affected by anemia caused by various illnesses. Variable Hb levels together with various levels of G6PD activity in field samples could partially explain the discrepancy of these 2 tests, although our laboratory assessment showed that the G6PD-deficient samples could be distinguished from G6PD-normal samples.
We also consider it possible that the discrepancy between two tests may be due to inaccurate evaluation by SSS. The definite cut-off level of coloring should be assessed by comparison of BFST and SSS using genetically confirmed samples.
Comparison of the results of SSS and BFST with the results of genetic analysis showed that 23 of 27 G6PD-deficient individuals detected by SSS, including two heterozygous females, had mutations (Table 3 ). All samples for which the results of SSS coincided with those of BFST were shown to have mutations, regardless of the anion exchanger used for the analysis. One case of class 2 G6PD mutation, 383 T--.0 (G6PD Vanua Lava), was detected among four cases that were diagnosed as `G6PD-deficient' using SSS with DEAE-SephacelTM but diagnosed as `G6PD normal' with BFST. This result suggests that some cases of G6PD deficiency may be undetectable using BFST, although a study showed that the G6PD-deficient hemizygotes could be distinguished from heterozygotes and normal controls using BFST (Pujades et al ., 1999) .
Including all reagents and disposable supplies, the estimated cost for one test of SSS with DEAE-Sephadex A-5OTM was approximately half that of a test of SSS with the DEAE-SephacelTM (0.15 US dollar and 0.30 US dollar, respectively). The cost of both of these systems is below an acceptable limit.
SSS is a quick, simple and reliable screening test for G6PD deficiency, although a larger field study is necessary for more precise evaluation of SSS. All the procedures in this test could be completed in field conditions without any electric equipment except during some preparations prior to the study. Using either anion exchanger, it can be used for quick detection of G6PD deficiency in various situations including field surveys, mass-treatment of malaria and differential diagnosis of hemolytic anemia, particularly in areas with substandard laboratory conditions. Although the whitecolored DEAE-SephacelTM gives better reaction visibility, the DEAE-Sephadex A-50TM system is more cost-effective, and is therefore preferable financially, particularly for field studies.
